{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T08:03:25Z","timestamp":1793865805927,"version":"4.6.1"},"reference-count":51,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2019,11,13]],"date-time":"2019-11-13T00:00:00Z","timestamp":1573603200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,11,13]],"date-time":"2019-11-13T00:00:00Z","timestamp":1573603200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100000054","name":"U.S. Department of Health & Human Services | NIH | National Cancer Institute","doi-asserted-by":"publisher","award":["R00CA143229"],"award-info":[{"award-number":["R00CA143229"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"U.S. Department of Health & Human Services | NIH | National Cancer Institute","doi-asserted-by":"publisher","award":["R01CA230628"],"award-info":[{"award-number":["R01CA230628"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"U.S. Department of Health & Human Services | NIH | National Cancer Institute","doi-asserted-by":"publisher","award":["R01CA230628"],"award-info":[{"award-number":["R01CA230628"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"name":"U.S. Department of Health & Human Services | NIH | National Cancer Institute"},{"DOI":"10.13039\/100002300","name":"Rivkin Center for Ovarian Cancer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100002300","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000090","name":"United States Department of Defense | United States Army | Army Medical Command | Congressionally Directed Medical Research Programs","doi-asserted-by":"publisher","award":["W81XWH-16-1-0117"],"award-info":[{"award-number":["W81XWH-16-1-0117"]}],"id":[{"id":"10.13039\/100000090","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100011597","name":"Penn State | Penn State College of Medicine | Penn State Hershey Cancer Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100011597","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004322","name":"Agilent Technologies","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004322","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"U.S. Department of Health & Human Services | National Institutes of Health","doi-asserted-by":"publisher","award":["S100D018124"],"award-info":[{"award-number":["S100D018124"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"name":"U.S. Department of Health & Human Services | NIH | National Cancer Institute"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Oncogene"],"published-print":{"date-parts":[[2020,2,20]]},"DOI":"10.1038\/s41388-019-1097-7","type":"journal-article","created":{"date-parts":[[2019,11,13]],"date-time":"2019-11-13T12:02:57Z","timestamp":1573646577000},"page":"1619-1633","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":62,"title":["Context-dependent activation of SIRT3 is necessary for anchorage-independent survival and metastasis of ovarian cancer cells"],"prefix":"10.1038","volume":"39","author":[{"given":"Yeon Soo","family":"Kim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Piyushi","family":"Gupta Vallur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victoria M.","family":"Jones","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beth L.","family":"Worley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Shimko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dong-Hui","family":"Shin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"LaTaijah C.","family":"Crawford","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chi-Wei","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katherine M.","family":"Aird","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Abraham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Trevor G.","family":"Shepherd","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joshua I.","family":"Warrick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nam Y.","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecca","family":"Phaeton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karthikeyan","family":"Mythreye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5574-8783","authenticated-orcid":false,"given":"Nadine","family":"Hempel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,11,13]]},"reference":[{"key":"1097_CR1","doi-asserted-by":"publisher","first-page":"284","DOI":"10.3322\/caac.21456","volume":"68","author":"LA Torre","year":"2018","unstructured":"Torre LA, Trabert B, DeSantis CE, Miller KD, Samimi G, Runowicz CD, et al. Ovarian cancer statistics, 2018. CA Cancer J Clin. 2018;68:284\u201396.","journal-title":"CA Cancer J Clin"},{"key":"1097_CR2","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1002\/jso.21288","volume":"99","author":"J Sehouli","year":"2009","unstructured":"Sehouli J, Senyuva F, Fotopoulou C, Neumann U, Denkert C, Werner L, et al. Intra-abdominal tumor dissemination pattern and surgical outcome in 214 patients with primary ovarian cancer. J Surg Oncol. 2009;99:424\u20137.","journal-title":"J Surg Oncol"},{"key":"1097_CR3","doi-asserted-by":"publisher","first-page":"925","DOI":"10.1016\/S1470-2045(06)70939-1","volume":"7","author":"DS Tan","year":"2006","unstructured":"Tan DS, Agarwal R, Kaye SB. Mechanisms of transcoelomic metastasis in ovarian cancer. Lancet Oncol. 2006;7:925\u201334.","journal-title":"Lancet Oncol"},{"key":"1097_CR4","doi-asserted-by":"publisher","first-page":"3315","DOI":"10.1038\/onc.2014.264","volume":"34","author":"Q Cai","year":"2015","unstructured":"Cai Q, Yan L, Xu Y. Anoikis resistance is a critical feature of highly aggressive ovarian cancer cells. Oncogene. 2015;34:3315\u201324.","journal-title":"Oncogene"},{"key":"1097_CR5","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1038\/nature15726","volume":"527","author":"E Piskounova","year":"2015","unstructured":"Piskounova E, Agathocleous M, Murphy MM, Hu Z, Huddlestun SE, Zhao Z, et al. Oxidative stress inhibits distant metastasis by human melanoma cells. Nature. 2015;527:186\u201391.","journal-title":"Nature"},{"key":"1097_CR6","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1038\/nature08268","volume":"461","author":"ZT Schafer","year":"2009","unstructured":"Schafer ZT, Grassian AR, Song L, Jiang Z, Gerhart-Hines Z, Irie HY, et al. Antioxidant and oncogene rescue of metabolic defects caused by loss of matrix attachment. Nature. 2009;461:109\u201313.","journal-title":"Nature"},{"key":"1097_CR7","doi-asserted-by":"publisher","first-page":"3704","DOI":"10.1158\/0008-5472.CAN-12-2482","volume":"73","author":"CA Davison","year":"2013","unstructured":"Davison CA, Durbin SM, Thau MR, Zellmer VR, Chapman SE, Diener J, et al. Antioxidant enzymes mediate survival of breast cancer cells deprived of extracellular matrix. Cancer Res. 2013;73:3704\u201315.","journal-title":"Cancer Res"},{"key":"1097_CR8","doi-asserted-by":"crossref","first-page":"308re308","DOI":"10.1126\/scitranslmed.aad3740","volume":"7","author":"K Le Gal","year":"2015","unstructured":"Le Gal K, Ibrahim MX, Wiel C, Sayin VI, Akula MK, Karlsson C, et al. Antioxidants can increase melanoma metastasis in mice. Sci Transl Med. 2015;7:308re308.","journal-title":"Sci Transl Med"},{"key":"1097_CR9","doi-asserted-by":"publisher","first-page":"662","DOI":"10.1016\/j.cmet.2010.11.015","volume":"12","author":"X Qiu","year":"2010","unstructured":"Qiu X, Brown K, Hirschey MD, Verdin E, Chen D. Calorie restriction reduces oxidative stress by SIRT3-mediated SOD2 activation. Cell Metab. 2010;12:662\u20137.","journal-title":"Cell Metab"},{"key":"1097_CR10","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1038\/embor.2011.65","volume":"12","author":"Y Chen","year":"2011","unstructured":"Chen Y, Zhang J, Lin Y, Lei Q, Guan KL, Zhao S, et al. Tumour suppressor SIRT3 deacetylates and activates manganese superoxide dismutase to scavenge ROS. EMBO Rep. 2011;12:534\u201341.","journal-title":"EMBO Rep"},{"key":"1097_CR11","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1016\/j.molcel.2010.12.013","volume":"40","author":"R Tao","year":"2010","unstructured":"Tao R, Coleman MC, Pennington JD, Ozden O, Park SH, Jiang H, et al. Sirt3-mediated deacetylation of evolutionarily conserved lysine 122 regulates MnSOD activity in response to stress. Mol Cell. 2010;40:893\u2013904.","journal-title":"Mol Cell"},{"key":"1097_CR12","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.ccr.2009.11.023","volume":"17","author":"HS Kim","year":"2010","unstructured":"Kim HS, Patel K, Muldoon-Jacobs K, Bisht KS, Aykin-Burns N, Pennington JD, et al. SIRT3 is a mitochondria-localized tumor suppressor required for maintenance of mitochondrial integrity and metabolism during stress. Cancer Cell. 2010;17:41\u201352.","journal-title":"Cancer Cell"},{"key":"1097_CR13","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0131344","volume":"10","author":"LM McGlynn","year":"2015","unstructured":"McGlynn LM, McCluney S, Jamieson NB, Thomson J, MacDonald AI, Oien K, et al. SIRT3 & SIRT7: potential novel biomarkers for determining outcome in pancreatic cancer patients. PloS ONE. 2015;10:e0131344.","journal-title":"PloS ONE"},{"key":"1097_CR14","doi-asserted-by":"publisher","first-page":"1071","DOI":"10.1016\/j.humpath.2014.01.004","volume":"45","author":"MM Desouki","year":"2014","unstructured":"Desouki MM, Doubinskaia I, Gius D, Abdulkadir SA. Decreased mitochondrial SIRT3 expression is a potential molecular biomarker associated with poor outcome in breast cancer. Hum Pathol. 2014;45:1071\u20137.","journal-title":"Hum Pathol"},{"key":"1097_CR15","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1016\/j.bbrc.2013.11.068","volume":"443","author":"B Yang","year":"2014","unstructured":"Yang B, Fu X, Shao L, Ding Y, Zeng D. Aberrant expression of SIRT3 is conversely correlated with the progression and prognosis of human gastric cancer. Biochem Biophys Res Commun. 2014;443:156\u201360.","journal-title":"Biochem Biophys Res Commun"},{"key":"1097_CR16","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0051703","volume":"7","author":"CZ Zhang","year":"2012","unstructured":"Zhang CZ, Liu L, Cai M, Pan Y, Fu J, Cao Y, et al. Low SIRT3 expression correlates with poor differentiation and unfavorable prognosis in primary hepatocellular carcinoma. PloS One. 2012;7:e51703.","journal-title":"PloS One"},{"key":"1097_CR17","doi-asserted-by":"publisher","first-page":"2157","DOI":"10.2147\/OTT.S157836","volume":"11","author":"Y Zhou","year":"2018","unstructured":"Zhou Y, Cheng S, Chen S, Zhao Y. Prognostic and clinicopathological value of SIRT3 expression in various cancers: a systematic review and meta-analysis. Onco Targets Ther. 2018;11:2157\u201367.","journal-title":"Onco Targets Ther"},{"key":"1097_CR18","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1016\/j.ccr.2011.02.014","volume":"19","author":"LW Finley","year":"2011","unstructured":"Finley LW, Carracedo A, Lee J, Souza A, Egia A, Zhang J, et al. SIRT3 opposes reprogramming of cancer cell metabolism through HIF1alpha destabilization. Cancer Cell. 2011;19:416\u201328.","journal-title":"Cancer Cell"},{"key":"1097_CR19","doi-asserted-by":"publisher","first-page":"3268","DOI":"10.1074\/jbc.M115.702076","volume":"291","author":"W Yu","year":"2016","unstructured":"Yu W, Denu RA, Krautkramer KA, Grindle KM, Yang DT, Asimakopoulos F, et al. Loss of SIRT3 Provides Growth Advantage for B Cell Malignancies. J Biol Chem. 2016;291:3268\u201379.","journal-title":"J Biol Chem"},{"key":"1097_CR20","doi-asserted-by":"publisher","first-page":"E86","DOI":"10.3390\/antiox6040086","volume":"6","author":"YS Kim","year":"2017","unstructured":"Kim YS, Gupta Vallur P, Phaeton R, Mythreye K, Hempel N. Insights into the dichotomous regulation of SOD2 in cancer. Antioxidants (Basel). 2017;6:E86.","journal-title":"Antioxidants (Basel)"},{"key":"1097_CR21","first-page":"80","volume":"1816","author":"TY Alhazzazi","year":"2011","unstructured":"Alhazzazi TY, Kamarajan P, Verdin E, Kapila YL. SIRT3 and cancer: tumor promoter or suppressor? Biochim Biophys Acta. 2011;1816:80\u201388.","journal-title":"Biochim Biophys Acta"},{"key":"1097_CR22","doi-asserted-by":"publisher","first-page":"1670","DOI":"10.1002\/cncr.25676","volume":"117","author":"TY Alhazzazi","year":"2011","unstructured":"Alhazzazi TY, Kamarajan P, Joo N, Huang JY, Verdin E, D\u2019Silva NJ, et al. Sirtuin-3 (SIRT3), a novel potential therapeutic target for oral cancer. Cancer. 2011;117:1670\u20138.","journal-title":"Cancer"},{"key":"1097_CR23","doi-asserted-by":"publisher","first-page":"916","DOI":"10.1016\/j.ccell.2019.05.002","volume":"35","author":"M Li","year":"2019","unstructured":"Li M, Chiang YL, Lyssiotis CA, Teater MR, Hong JY, Shen H, et al. Non-oncogene addiction to SIRT3 plays a critical role in lymphomagenesis. Cancer Cell. 2019;35:916\u2013931 e919.","journal-title":"Cancer Cell"},{"key":"1097_CR24","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-018-06812-y","volume":"9","author":"Z Wei","year":"2018","unstructured":"Wei Z, Song J, Wang G, Cui X, Zheng J, Tang Y, et al. Deacetylation of serine hydroxymethyl-transferase 2 by SIRT3 promotes colorectal carcinogenesis. Nat Commun. 2018;9:4468.","journal-title":"Nat Commun"},{"key":"1097_CR25","doi-asserted-by":"publisher","first-page":"1369","DOI":"10.1158\/0008-5472.CAN-18-3712","volume":"79","author":"HK Park","year":"2019","unstructured":"Park HK, Hong JH, Oh YT, Kim SS, Yin J, Lee AJ, et al. Interplay between TRAP1 and sirtuin-3 modulates mitochondrial respiration and oxidative stress to maintain stemness of glioma stem cells. Cancer Res. 2019;79:1369\u201382.","journal-title":"Cancer Res"},{"key":"1097_CR26","doi-asserted-by":"publisher","first-page":"4393","DOI":"10.1038\/onc.2017.52","volume":"36","author":"TC Kenny","year":"2017","unstructured":"Kenny TC, Hart P, Ragazzi M, Sersinghe M, Chipuk J, Sagar MAK, et al. Selected mitochondrial DNA landscapes activate the SIRT3 axis of the UPR(mt) to promote metastasis. Oncogene. 2017;36:4393\u2013404.","journal-title":"Oncogene"},{"key":"1097_CR27","doi-asserted-by":"publisher","first-page":"1396","DOI":"10.1242\/jcs.078220","volume":"124","author":"L Papa","year":"2011","unstructured":"Papa L, Germain D. Estrogen receptor mediates a distinct mitochondrial unfolded protein response. J Cell Sci. 2011;124:1396\u2013402.","journal-title":"J Cell Sci"},{"key":"1097_CR28","doi-asserted-by":"publisher","first-page":"773","DOI":"10.3892\/ijo.2016.3552","volume":"49","author":"XY Xiang","year":"2016","unstructured":"Xiang XY, Kang JS, Yang XC, Su J, Wu Y, Yan XY, et al. SIRT3 participates in glucose metabolism interruption and apoptosis induced by BH3 mimetic S1 in ovarian cancer cells. Int J Oncol. 2016;49:773\u201384.","journal-title":"Int J Oncol"},{"key":"1097_CR29","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1016\/j.bbrc.2016.05.098","volume":"475","author":"XC Dong","year":"2016","unstructured":"Dong XC, Jing LM, Wang WX, Gao YX. Down-regulation of SIRT3 promotes ovarian carcinoma metastasis. Biochem Biophys Res Commun. 2016;475:245\u201350.","journal-title":"Biochem Biophys Res Commun"},{"key":"1097_CR30","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1038\/nature17393","volume":"532","author":"L Jiang","year":"2016","unstructured":"Jiang L, Shestov AA, Swain P, Yang C, Parker SJ, Wang QA, et al. Reductive carboxylation supports redox homeostasis during anchorage-independent growth. Nature. 2016;532:255\u20138.","journal-title":"Nature"},{"key":"1097_CR31","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1016\/j.neuroscience.2015.10.048","volume":"311","author":"P Rangarajan","year":"2015","unstructured":"Rangarajan P, Karthikeyan A, Lu J, Ling EA, Dheen ST. Sirtuin 3 regulates Foxo3a-mediated antioxidant pathway in microglia. Neuroscience. 2015;311:398\u2013414.","journal-title":"Neuroscience"},{"key":"1097_CR32","doi-asserted-by":"publisher","first-page":"2986","DOI":"10.1038\/onc.2011.37","volume":"30","author":"EL Bell","year":"2011","unstructured":"Bell EL, Emerling BM, Ricoult SJ, Guarente L. SirT3 suppresses hypoxia inducible factor 1alpha and tumor growth by inhibiting mitochondrial ROS production. Oncogene. 2011;30:2986\u201396.","journal-title":"Oncogene"},{"key":"1097_CR33","doi-asserted-by":"publisher","first-page":"2503","DOI":"10.1158\/0008-5472.CAN-17-2618","volume":"78","author":"J Hou","year":"2018","unstructured":"Hou J, Williams J, Botvinick EL, Potma EO, Tromberg BJ. Visualization of breast cancer metabolism using multimodal nonlinear optical microscopy of cellular lipids and redox state. Cancer Res. 2018;78:2503\u201312.","journal-title":"Cancer Res"},{"key":"1097_CR34","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1093\/carcin\/bgr241","volume":"33","author":"RJ Correa","year":"2012","unstructured":"Correa RJ, Peart T, Valdes YR, DiMattia GE, Shepherd TG. Modulation of AKT activity is associated with reversible dormancy in ascites-derived epithelial ovarian cancer spheroids. Carcinogenesis. 2012;33:49\u201358.","journal-title":"Carcinogenesis"},{"key":"1097_CR35","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms7220","volume":"6","author":"HA Kenny","year":"2015","unstructured":"Kenny HA, Lal-Nag M, White EA, Shen M, Chiang CY, Mitra AK, et al. Quantitative high throughput screening using a primary human three-dimensional organotypic culture predicts in vivo efficacy. Nat Commun. 2015;6:6220.","journal-title":"Nat Commun"},{"key":"1097_CR36","doi-asserted-by":"publisher","first-page":"5800","DOI":"10.1002\/cncr.27655","volume":"118","author":"P Kamarajan","year":"2012","unstructured":"Kamarajan P, Alhazzazi TY, Danciu T, D\u2019Silva NJ, Verdin E, Kapila YL. Receptor-interacting protein (RIP) and Sirtuin-3 (SIRT3) are on opposite sides of anoikis and tumorigenesis. Cancer. 2012;118:5800\u201310.","journal-title":"Cancer"},{"key":"1097_CR37","doi-asserted-by":"publisher","first-page":"2292","DOI":"10.1016\/j.celrep.2019.04.095","volume":"27","author":"TC Kenny","year":"2019","unstructured":"Kenny TC, Craig AJ, Villanueva A, Germain D. Mitohormesis primes tumor invasion and metastasis. Cell Rep. 2019;27:2292\u20132303. e2296.","journal-title":"Cell Rep"},{"key":"1097_CR38","doi-asserted-by":"publisher","first-page":"191","DOI":"10.2174\/187152011795255911","volume":"11","author":"N Hempel","year":"2011","unstructured":"Hempel N, Carrico PM, Melendez JA. Manganese superoxide dismutase (Sod2) and redox-control of signaling events that drive metastasis. Anticancer Agents Med Chem. 2011;11:191\u2013201.","journal-title":"Anticancer Agents Med Chem"},{"key":"1097_CR39","doi-asserted-by":"publisher","first-page":"4973","DOI":"10.1158\/0008-5472.CAN-14-3799","volume":"75","author":"LP Hemachandra","year":"2015","unstructured":"Hemachandra LP, Shin DH, Dier U, Iuliano JN, Engelberth SA, Uusitalo LM, et al. Mitochondrial superoxide dismutase has a protumorigenic role in ovarian clear cell carcinoma. Cancer Res. 2015;75:4973\u201384.","journal-title":"Cancer Res"},{"key":"1097_CR40","doi-asserted-by":"publisher","first-page":"10260","DOI":"10.1158\/0008-5472.CAN-07-1204","volume":"67","author":"KM Connor","year":"2007","unstructured":"Connor KM, Hempel N, Nelson KK, Dabiri G, Gamarra A, Belarmino J, et al. Manganese superoxide dismutase enhances the invasive and migratory activity of tumor cells. Cancer Res. 2007;67:10260\u20137.","journal-title":"Cancer Res"},{"key":"1097_CR41","doi-asserted-by":"publisher","first-page":"3990","DOI":"10.1158\/0008-5472.CAN-16-2393","volume":"77","author":"X Zou","year":"2017","unstructured":"Zou X, Zhu Y, Park SH, Liu G, O\u2019Brien J, Jiang H, et al. SIRT3-mediated dimerization of IDH2 directs cancer cell metabolism and tumor growth. Cancer Res. 2017;77:3990\u20139.","journal-title":"Cancer Res"},{"key":"1097_CR42","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/j.freeradbiomed.2014.08.001","volume":"76","author":"O Ozden","year":"2014","unstructured":"Ozden O, Park SH, Wagner BA, Yong Song H, Zhu Y, Vassilopoulos A, et al. SIRT3 deacetylates and increases pyruvate dehydrogenase activity in cancer cells. Free Radic Biol Med. 2014;76:163\u201372.","journal-title":"Free Radic Biol Med"},{"key":"1097_CR43","doi-asserted-by":"publisher","first-page":"3404","DOI":"10.2337\/db12-1650","volume":"62","author":"E Jing","year":"2013","unstructured":"Jing E, O\u2019Neill BT, Rardin MJ, Kleinridders A, Ilkeyeva OR, Ussar S, et al. Sirt3 regulates metabolic flexibility of skeletal muscle through reversible enzymatic deacetylation. Diabetes. 2013;62:3404\u201317.","journal-title":"Diabetes"},{"key":"1097_CR44","doi-asserted-by":"publisher","first-page":"E229","DOI":"10.3390\/ijms20010229","volume":"20","author":"E Emmings","year":"2019","unstructured":"Emmings E, Mullany S, Chang Z, Landen CN Jr., Linder S, Bazzaro M. Targeting mitochondria for treatment of chemoresistant ovarian cancer. Int J Mol Sci. 2019;20:E229.","journal-title":"Int J Mol Sci"},{"key":"1097_CR45","doi-asserted-by":"publisher","first-page":"1498","DOI":"10.1038\/nm.2492","volume":"17","author":"KM Nieman","year":"2011","unstructured":"Nieman KM, Kenny HA, Penicka CV, Ladanyi A, Buell-Gutbrod R, Zillhardt MR, et al. Adipocytes promote ovarian cancer metastasis and provide energy for rapid tumor growth. Nat Med. 2011;17:1498\u2013503.","journal-title":"Nat Med"},{"key":"1097_CR46","doi-asserted-by":"publisher","first-page":"2643","DOI":"10.1038\/nprot.2006.328","volume":"1","author":"TG Shepherd","year":"2006","unstructured":"Shepherd TG, Theriault BL, Campbell EJ, Nachtigal MW. Primary culture of ovarian surface epithelial cells and ascites-derived ovarian cancer cells from patients. Nat Protoc. 2006;1:2643\u20139.","journal-title":"Nat Protoc"},{"key":"1097_CR47","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1007\/s10585-011-9451-3","volume":"29","author":"TM Peart","year":"2012","unstructured":"Peart TM, Correa RJ, Valdes YR, Dimattia GE, Shepherd TG. BMP signalling controls the malignant potential of ascites-derived human epithelial ovarian cancer spheroids via AKT kinase activation. Clin Exp Metastasis. 2012;29:293\u2013313.","journal-title":"Clin Exp Metastasis"},{"key":"1097_CR48","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0098479","volume":"9","author":"U Dier","year":"2014","unstructured":"Dier U, Shin DH, Hemachandra LP, Uusitalo LM, Hempel N. Bioenergetic analysis of ovarian cancer cell lines: profiling of histological subtypes and identification of a mitochondria-defective cell line. PloS ONE. 2014;9:e98479.","journal-title":"PloS ONE"},{"key":"1097_CR49","first-page":"101051","volume":"17","author":"BL Worley","year":"2018","unstructured":"Worley BL, Kim YS, Mardini J, Zaman R, Leon KE, Vallur PG, et al. GPx3 supports ovarian cancer progression by manipulating the extracellular redox environment. Redox Biol. 2018;17:101051.","journal-title":"Redox Biol"},{"key":"1097_CR50","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1016\/0003-2697(71)90370-8","volume":"44","author":"C Beauchamp","year":"1971","unstructured":"Beauchamp C, Fridovich I. Superoxide dismutase: improved assays and an assay applicable to acrylamide gels. Anal Biochem. 1971;44:276\u201387.","journal-title":"Anal Biochem"},{"key":"1097_CR51","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/j.freeradbiomed.2008.09.020","volume":"46","author":"N Hempel","year":"2009","unstructured":"Hempel N, Ye H, Abessi B, Mian B, Melendez JA. Altered redox status accompanies progression to metastatic human bladder cancer. Free Radic Biol Med. 2009;46:42\u201350.","journal-title":"Free Radic Biol Med"}],"container-title":["Oncogene"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41388-019-1097-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41388-019-1097-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41388-019-1097-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,17]],"date-time":"2022-04-17T05:04:20Z","timestamp":1650171860000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41388-019-1097-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,11,13]]},"references-count":51,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2020,2,20]]}},"alternative-id":["1097"],"URL":"https:\/\/doi.org\/10.1038\/s41388-019-1097-7","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/670778","asserted-by":"object"}]},"ISSN":["0950-9232","1476-5594"],"issn-type":[{"value":"0950-9232","type":"print"},{"value":"1476-5594","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,11,13]]},"assertion":[{"value":"6 June 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 October 2019","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 November 2019","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 November 2019","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}